SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as community members discuss its long-term potential, with many users sharing optimism that the project will eventually rebound from its current lows. Discussions frequently highlight the earn-while-moving model and the importance of patience, often referencing the token alongside the NEAR protocol.

MNDE is the governance token for Marinade. Marinade helps you to stake Solana without locking in liquidity by turning SOL into mSOL - tokenized version of staked SOL. This way you can both secure the network by staking SOL, and use your mSOL as the ultimate unit in Solana DeFi ecosystem. To provide liquidity, deposit in lending protocols and even buy NFTs.

Marinade

Marinade is trending as community members highlight its low market cap relative to its substantial total value locked, leading to active discussions about potential undervaluation. Investors are closely watching for technical breakouts and increased volume, viewing it as a key play within the Solana ecosystem.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is generating significant community interest driven by its expanding AI-centric infrastructure and the growing adoption of its 'Intents' cross-chain swap protocol. Investors are actively discussing the token's long-term utility in the AI economy, with many viewing current price levels as an accumulation opportunity despite broader market volatility.

Photronics, Inc. engages in the provision of photomasks, which are quartz or glass plates containing microscopic images of electronic circuits for use in the fabrication of integrated circuits and flat-panel displays. The company was founded by Constantine S. Macricostas in 1969 and is headquartered in Brookfield, CT.

Photronics, Inc.

Photronics is drawing attention as a potential value play in the semiconductor supply chain, with investors closely watching its critical role as a photomask supplier amidst the ongoing AI infrastructure expansion. The community is actively discussing the stock's low valuation relative to its cash position, while monitoring for a breakout from its multi-year base as market participants weigh the company's long-term growth potential against current sector volatility.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is experiencing significant investor focus following a strategic partnership with Volkswagen to implement VLA 2.0 autonomous driving technology, a move seen by many as a critical validation of its technological moat. While some community members remain wary of ongoing price volatility and the broader regulatory climate surrounding Chinese equities, others are actively accumulating shares on dips, betting that the company's long-term expansion into AI, robotics, and global markets will eventually overcome current headwinds.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant (QNT) is trending as investors debate its long-term utility in banking interoperability versus its recent periods of stagnant price action. Community sentiment remains polarized, with many holders accumulating positions at lower levels in anticipation of future institutional adoption, while others express frustration over the token's inability to sustain upward momentum.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grumman is trending as investors weigh strong long-term backlog and critical B-21 program progress against concerns over near-term capital expenditure spikes and broader sector rotation. While community sentiment remains polarized between frustration over recent price volatility and conviction in the stock as a long-term defense foundation, analysts continue to highlight the company's role in essential military modernization as a key driver for potential recovery.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto is seeing heightened volatility as investors weigh disappointing delivery figures against the company's upcoming launch of the i6 SUV and ongoing AI initiatives. The stock remains a focal point for community debate, with bulls highlighting the potential of the new product cycle, while bears point to cooling domestic demand and intensifying competition within the Chinese EV sector.

Tractor Supply Co. engages in the retail sale of farm and ranch products. It operates retail farm and ranch stores and focuses on supplying the lifestyle needs of recreational farmers and ranchers, as well as tradesmen and small businesses. The firm operates the retail stores under the names: Tractor Supply Company, Orscheln Farm & Home, and Petsense. Its product categories include equine, livestock, pet, and small animal, hardware, truck, towing, and tool, heating, lawn and garden items, power equipment, gifts, and toys, recreational clothing and footwear, and maintenance products for agricultural and rural use. The company was founded by Charles E. Schmidt, Sr. in 1938 and is headquartered in Brentwood, TN.

Tractor Supply Co.

Tractor Supply Co. is trending as analysts adjust their ratings, with Citigroup upgrading TSCO to a buy, while others adjust price targets; Evercore ISI Group updates rating to In-Line. The community is discussing the company's potential for growth, with some pointing to its e-commerce and pet-related retail segments, while others focus on expansion plans and operational efficiency.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is trending as investors highlight the company's unique position in the MRAM memory sector, specifically citing its critical role in radiation-hardened applications for aerospace and defense as a key catalyst. While some market participants debate the impact of ongoing legal proceedings and valuation concerns, the community is actively discussing the potential for a short squeeze and long-term growth driven by high-margin government contracts and increasing demand for specialized memory in AI and industrial edge computing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

In a recent article, eXoZymes (Nasdaq: $EXOZ ) was featured in The Village Voice for its work on NCT (N-trans-Caffeoyltyramine), a naturally occurring molecule at the center of a growing scientific conversation about metabolic health beyond GLP-1 weight-loss drugs. 
 
eXoZymes is a B2i Digital Featured Company. See their full profile at https://b2idigital.com/exozymes-1. 
 
eXoZymes has developed cell-free biomanufacturing methods capable of producing high-purity NCT at scale, turning a molecule once found only in trace amounts in peppercorns (roughly 0.0014 percent concentration) into one that can now be explored in depth. The article places that capability in the context of a broader shift in metabolic health research, where scientists are looking past appetite suppression toward approaches that address how the body burns energy at the cellular level. 
 
With over 1.4 billion people worldwide affected by obesity, diabetes, and metabolic dysfunction, the interest is growing. Preclinical research published in Nature Cell Death &amp; Disease showed a roughly 30 percent reduction in weight gain in mouse models on a high-fat diet receiving NCT, with no change in food intake. While further studies are required before conclusions about human health can be drawn, the Village Voice piece places eXoZymes squarely at the forefront of the ongoing effort to produce the NCT molecule at scale. 
 
Read the complete article: https://www.villagevoice.com/the-metabolic-engine-how-scientists-are-exploring-a-new-path-beyond-glp-1-weight-loss-drugs/ 
 
eXoZymes is a Los Angeles, California-based biotechnology company pioneering cell-free biomanufacturing through AI-engineered enzymes that transform sustainable feedstock into nutraceuticals, medicines, and essential chemicals. The company’s proprietary exozyme platform offers a scalable, eco-friendly alternative to traditional petrochemical processes, with technology validated through publications in Nature Communications and Nature Chemical Biology. Recently demonstrating gram-scale production of NCT with over 99% purity in just five months, eXoZymes focuses on high-value products including active pharmaceutical ingredients, nutraceuticals, and sustainable aviation fuel. 
 
eXoZymes is led by an experienced management team including Michael Heltzen, CEO; Damien Perriman, CCO; Dr. Tyler Korman, CSO and Co-founder; Dr. Paul Opgenorth, VP of Development and Co-founder; Fouad Nawaz, VP of Finance; Lasse H. Görlitz, VP of Communications; and Amy Lunzer, Chief of Staff. 
 
Learn more about eXoZymes Inc. at https://exozymes.com. For investor inquiries, visit https://exozymes.com/investor and learn about other B2i Digital Featured Companies at https://b2idigital.com/featured-companies. 
 
Disclosure: David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted EXOZ stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. This post is not intended to solicit the sale of EXOZ or any security, and it is not intended to offer any opinion on EXOZ as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the complete disclosure in the Risks and Disclosures section of https://b2idigital.com/disclaimer. 
 
$DNLI, $TWST, $DNA, $ARKG

David Shapiro

Brogley Panzarella

Ball Terjova

Ria Thiel

Allie Walker

Bana Daerhova

Refugio Bergstrom

James

top moon

Mangine Mckelvy

Cal Dwan

Tyree

Prince

Julio

Dwight

Edward

Alfredo

harry josh

Craig Salinas

Michael Musto

Henry Callaghan

John Park

Melissa Vermillion

Shirley Hall

Micheal Fikes

James Adair

Kelly Distaffen

Renee Blankenship

Nina Studdard

eXoZymes Inc. (Nasdaq: EXOZ) is a biotechnology company that has developed a new way to produce chemicals without using living cells. The company's technology, called "exozymes," combines enzymes (proteins that speed up chemical reactions) with artificial intelligence to create a manufacturing platform that transforms biomass into chemicals, medicines, and fuels.

B2idigital

eXoZymes Inc. | Nasdaq: EXOZ | B2i Digital Featured Company

eXoZymes is redefining how complex molecules are discovered, manufactured, and commercialized. Its AI-enhanced, cell-free biomanufacturing platform turns rare, unscalable, or economically inaccessible chemistry into predictable, high-purity production. By embedding manufacturability directly into discovery, eXoZymes collapses development timelines, lowers capital intensity, and unlocks multiple commercialization paths.

Exozymes

Home - eXoZymes leading the next generation of biomanufacturing

Chemicals are everywhere around us. They're in our medicine, fuel, plastic, food, and most colors, to name a few applications. Biochemical extraction is often inefficient, and petrochemical production is toxic and polluting.

Investor

Learn more about B2i Digital's portfolio of companies.

Featured Companies

Disclaimer - Content is provided "as is" by companies featured on the site. Conduct a trusted advisory before making investments.

Disclaimer - Consult and advisor before making any investments

StockTwits Web

eXoZymes Inc.

Denali Therapeutics Inc

Twist Bioscience Corp

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

ARK Investment Management LLC - ARK Genomic Revolution ETF

 ) was featured in The Village Voice for its work on NCT (N-trans-Caffeoyltyramine), a naturally occurring molecule at the center of a growing scientific conversation about metabolic health beyond GLP-1 weight-loss drugs. 
 
eXoZymes is a B2i Digital Featured Company. See their full profile at 

. 
 
eXoZymes has developed cell-free biomanufacturing methods capable of producing high-purity NCT at scale, turning a molecule once found only in trace amounts in peppercorns (roughly 0.0014 percent concentration) into one that can now be explored in depth. The article places that capability in the context of a broader shift in metabolic health research, where scientists are looking past appetite suppression toward approaches that address how the body burns energy at the cellular level. 
 
With over 1.4 billion people worldwide affected by obesity, diabetes, and metabolic dysfunction, the interest is growing. Preclinical research published in Nature Cell Death & Disease showed a roughly 30 percent reduction in weight gain in mouse models on a high-fat diet receiving NCT, with no change in food intake. While further studies are required before conclusions about human health can be drawn, the Village Voice piece places eXoZymes squarely at the forefront of the ongoing effort to produce the NCT molecule at scale. 
 
Read the complete article: 

 
 
eXoZymes is a Los Angeles, California-based biotechnology company pioneering cell-free biomanufacturing through AI-engineered enzymes that transform sustainable feedstock into nutraceuticals, medicines, and essential chemicals. The company’s proprietary exozyme platform offers a scalable, eco-friendly alternative to traditional petrochemical processes, with technology validated through publications in Nature Communications and Nature Chemical Biology. Recently demonstrating gram-scale production of NCT with over 99% purity in just five months, eXoZymes focuses on high-value products including active pharmaceutical ingredients, nutraceuticals, and sustainable aviation fuel. 
 
eXoZymes is led by an experienced management team including Michael Heltzen, CEO; Damien Perriman, CCO; Dr. Tyler Korman, CSO and Co-founder; Dr. Paul Opgenorth, VP of Development and Co-founder; Fouad Nawaz, VP of Finance; Lasse H. Görlitz, VP of Communications; and Amy Lunzer, Chief of Staff. 
 
Learn more about eXoZymes Inc. at 

/investor and learn about other B2i Digital Featured Companies at 

. 
 
Disclosure: David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted EXOZ stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. This post is not intended to solicit the sale of EXOZ or any security, and it is not intended to offer any opinion on EXOZ as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the complete disclosure in the Risks and Disclosures section of 

eXoZymes’ work on NCT highlights a compelling shift in metabolic health research, moving beyond appetite control toward cellular energy optimization. Their ability to produce this molecule at scale opens the door to deeper scientific exploration with real-world potential. 
 
See eXoZymes’ full Featured Company profile at https://b2idigital.com/exozymes-1

eXoZymes’ work on NCT highlights a compelling shift in metabolic health research, moving beyond appetite control toward cellular energy optimization. Their ability to produce this molecule at scale opens the door to deeper scientific exploration with real-world potential. 
 
See eXoZymes’ full Featured Company profile at 